Silo Pharma, Inc. /
MAVS Holdings LLC
Silo Pharma agrees to purchase software and domain names from MAVS Holdings LLC




Source for the buyer and target: Silo Pharma, Inc.
For the buyer and target.
“On July 29, 2025, Silo Pharma, Inc. (the “Company”) entered into an asset purchase agreement (the “Agreement”) with MAVS Holdings LLC (the “Seller”).”
Published 29 Jul 2025
Open the sourceWhat happened
Silo Pharma, Inc. entered into an asset purchase agreement with MAVS Holdings LLC for certain software associated with the web-based application r2crypto.com and three domain names. The consideration is 750,000 shares of Silo Pharma common stock. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Silo Pharma agrees to purchase software and domain names from MAVS Holdings LLC
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly